Urabe A, Takaku F, Kitagawa S, Miura Y, Dan K, Nomura T, Masuda M, Mizoguchi H, Yano T, Toyama K
Jpn J Antibiot. 1987 Apr;40(4):749-58.
Clavulanic acid/ticarcillin (BRL 28500) was administered to 36 patients with severe infections accompanying various hematological diseases. The rate of efficacy was 52% on the whole. Adverse reactions were minimal.